Health Care Reform that Works for All

January 13, 2022 Dear Members of Congress: As America’s small business owners continue to navigate a host of challenges and work to stabilize their firms and recover from the effects of the COVID-19 pandemic, we believe that Congress must focus on policy solutions that restore their vibrancy and growth. Our national and local economies depend […]

For Immediate Release December 20, 2021 Washington, D.C. – Today, the Small Business & Entrepreneurship Council (SBE Council) and the United States Hispanic Chamber of Commerce (USHCC) released the results of a poll examining the top policy concerns among the small business community and highlighting the need for Congress to focus on policies that aid […]

In a TownHall.com Op-ed, SBE Council president & CEO Karen Kerrigan details one of the many problems with the “Build Back Better Act.”  Specifically, the price controls in the legislation would greatly undermine U.S. investment, innovation and access to new life-saving drugs. Kerrigan writes: “The impact on business would be enormous. An analysis by the […]

TO THE MEMBERS OF THE U.S. HOUSE OF REPRESENTATIVES: We, the undersigned organizations, represent the interests of every sector and segment of the business community and together unequivocally oppose H.R. 3, the “Lower Drug Costs Now Act of 2019.” Promises to pass along government price controls to the employer-sponsored market do not change our fervent […]

  The Honorable Chuck Schumer Majority Leader United States Senate Washington, DC 20510 The Honorable Mitch McConnell Republican Leader United States Senate Washington, DC 20510 The Honorable Nancy Pelosi Speaker United States House of Representatives Washington, DC 20515 The Honorable Kevin McCarthy Republican Leader United States House of Representatives Washington, DC 20515 Dear Leader Schumer, […]

by Raymond J. Keating – Regulations – including price controls – always fall heaviest on smaller, entrepreneurial enterprises. That is very much the case in the biopharmaceutical industry. Price controls on prescription drugs would undermine entrepreneurship and private investment in the industry, and therefore, would undermine the creation of new and improved drugs, medicines and […]

Dear Member of Congress: A few rogue “employer groups” who do not represent the interest of their member companies or the business community are pushing for price controls on prescription drugs, punitive taxes on pharmaceutical companies, and more government meddling in our health care system. Millions of small to mid-size companies across the United States […]

Executive Order on “Competition” Would Damage Innovation, Endanger Health Consumers by RAYMOND J. KEATING – I’ve said it before, and I’ll say it again: I’m always bewildered by the political attacks on pharmaceutical companies. After all, these businesses produce medicines, drugs and vaccines that improve and save lives. Why attack and undermine such worthy endeavors? […]

In a July 28 Washington Times Op-Ed, SBE Council president & CEO Karen Kerrigan writes that federal government policy is moving in a direction that is not supported, or helpful to, small businesses. She points to a recent Morning Consult survey sponsored by SBE Council that reveals key findings: Unfortunately, the solutions being advocated and […]

In this week’s Growth Without Barriers podcast, SBE Council president & CEO Karen Kerrigan discusses why it is important for Congress and the Biden Administration to listen to small business owners on health care policy. According to a new Morning Consult survey sponsored by SBE Council, small business owners want freedom and flexibility, they want […]